Screening for prostate cancer: recommendation and rationale
- PMID: 12458992
- DOI: 10.7326/0003-4819-137-11-200212030-00013
Screening for prostate cancer: recommendation and rationale
Comment in
-
Screening for prostate cancer.Ann Intern Med. 2003 Sep 16;139(6):531-2; discussion 532. doi: 10.7326/0003-4819-139-6-200309160-00030. Ann Intern Med. 2003. PMID: 13679340 No abstract available.
-
Screening for prostate cancer.Ann Intern Med. 2003 Sep 16;139(6):531; discussion 532. doi: 10.7326/0003-4819-139-6-200309160-00029. Ann Intern Med. 2003. PMID: 13679341 No abstract available.
-
Screening for prostate cancer: recommendation and rationale.J Urol. 2003 Jul;170(1):313. J Urol. 2003. PMID: 14565223 No abstract available.
Similar articles
-
Summaries for patients. Screening for prostate cancer: a recommendation from the U.S. Preventive Services Task Force.Ann Intern Med. 2002 Dec 3;137(11):I48. doi: 10.7326/0003-4819-137-11-200212030-00005. Ann Intern Med. 2002. PMID: 12459001 No abstract available.
-
Screening for prostate cancer: recommendations and rationale.Am J Nurs. 2003 Mar;103(3):107-10; discussion 111. Am J Nurs. 2003. PMID: 12626949 No abstract available.
-
Screening for prostate cancer. American College of Physicians.Ann Intern Med. 1997 Mar 15;126(6):480-4. Ann Intern Med. 1997. PMID: 9072936 Review. No abstract available.
-
Screening for prostate cancer: informing men about their options.Clin J Oncol Nurs. 2005 Oct;9(5):625-7. doi: 10.1188/05.CJON.625-627. Clin J Oncol Nurs. 2005. PMID: 16235590 Review. No abstract available.
-
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.Ann Intern Med. 2008 Aug 5;149(3):185-91. doi: 10.7326/0003-4819-149-3-200808050-00008. Ann Intern Med. 2008. PMID: 18678845
Cited by
-
Population-Based Cancer Survival in Canada and the United States by Socioeconomic Status: Findings from the CONCORD-2 Study.J Registry Manag. 2022 Spring;49(1):23-33. J Registry Manag. 2022. PMID: 37260622 Free PMC article.
-
Number of prostate-specific antigen (PSA) screening tests in the last five years reported by men in the United States in 2010, 2015, and 2018.Urol Oncol. 2022 May;40(5):192.e19-192.e25. doi: 10.1016/j.urolonc.2022.01.016. Epub 2022 Feb 27. Urol Oncol. 2022. PMID: 35236620 Free PMC article.
-
Interleukin-13 rs1800925/-1112C/T promoter single nucleotide polymorphism variant linked to anti-schistosomiasis in adult males in Murehwa District, Zimbabwe.PLoS One. 2021 May 28;16(5):e0252220. doi: 10.1371/journal.pone.0252220. eCollection 2021. PLoS One. 2021. PMID: 34048465 Free PMC article.
-
Trends in prostate cancer incidence and mortality to monitor control policies in a northeastern Brazilian state.PLoS One. 2021 Mar 25;16(3):e0249009. doi: 10.1371/journal.pone.0249009. eCollection 2021. PLoS One. 2021. PMID: 33765051 Free PMC article.
-
Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation.J Natl Cancer Inst. 2021 Jun 1;113(6):719-726. doi: 10.1093/jnci/djaa171. J Natl Cancer Inst. 2021. PMID: 33146392 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical